Centiva Capital’s Oculis Holding OCS Stock Holding History

Centiva Capital’s Portfolio OCS Stock Details OCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-18,145	Closed	-$482K	–	2115
2026 Q1	$482K	Buy	+18,145	New	+$480K	﹤0.01%	867

Other funds holding OCS

EFM

EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

SVCM

Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Centiva Capital's OCS Position: Q2 2026 in Review

Centiva Capital sold out of Oculis Holding (OCS) in Q2 2026, closing a stake of 18,145 shares — an estimated $482K sold.

Centiva Capital first reported a position in OCS in Q1 2026 and held it in 1 quarter. The position peaked at $482K in Q1 2026. 59 funds tracked by Wall St. Rank hold OCS as of Q2 2026.

Centiva Capital reported no remaining Oculis Holding position as of Q2 2026 after selling out during the quarter.
Centiva Capital sold 18,145 Oculis Holding shares in Q2 2026, an estimated $482K.
Centiva Capital first reported a position in Oculis Holding in Q1 2026 and held it in 1 quarter.
Centiva Capital's Oculis Holding position peaked at $482K in Q1 2026.
59 funds tracked by Wall St. Rank held Oculis Holding as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.